Navigation Links
Glysure Appoints Justine McQuillan as European Director of Clinical Affairs
Date:9/25/2013

OXFORD, England, September 25, 2013 /PRNewswire/ --

GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, today announced the appointment of Justine McQuillan as its European Director of Clinical Affairs. In this newly established position, McQuillan is leading European clinical regulatory trials of GlySure's CBGM technology, which the company expects to complete this fall.

McQuillan has extensive clinical, operational and commercial experience within the MedTech industry, with expertise in the development, evaluation and validation, regulatory clearance and marketing of medical devices and supporting services. She spent eight years at Medicsight PLC, having most recently served as Vice President of Clinical Development. In this role, McQuillan planned, implemented and managed the clinical regulatory strategy to support European, U.S., Chinese and Japanese submissions for regulatory clearance of the company's computer-aided detection medical image analysis products.

"McQuillan's knowledge and experience in successfully guiding a company from R&D through regulatory trials and all the way through to commercialization are the exact qualities we need at this critical juncture of our development," said GlySure CEO Chris Jones. "In addition to leading efforts to secure a CE mark, McQuillan will be working closely with our U.S. trial sites to prepare for U.S. FDA 510(k) regulatory trials."

McQuillan holds a Master of Business Administration from the University of Westminster, London, a Post-graduate Diploma in Management from University of London, and a Diploma in Medical Diagnostic Imaging from Auckland School of Radiography, New Zealand.

About GlySure:

GlySure has developed a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor to meet the $2B+ worldwide demand for implementation of Tight Glycemic Control (TGC) in the hospital Intensive Care Unit (ICU).  The company has demonstrated through ICU testing highly accurate sensors which can provide continuous glucose readings throughout the length of a patient's stay in the ICU.  GlySure was founded in 2006, it is based in Abingdon, Oxfordshire, England and it has 30 employees. The company's products are not approved for use in the U.S. or Europe. http://www.glysure.com

Company Contact: Chris Jones, CEO, GlySure. Tel: +44(0)1235-462-870. cjones@glysure.com

Media Contact: Kara Della Vecchia, KDV Communications, Inc. Tel: +1-508-314-3127. kara@kdvcommunications.com


'/>"/>
SOURCE GlySure
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlySure Earns ISO 13485 Certification
2. GlySure CEO to Present ICU Trial Results at Spring Medtech Industry Conferences
3. Study Demonstrates Glysure Systems Ability to Accurately Measure Blood Glucose Levels in the ICU
4. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
5. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
6. Nephros Appoints John C. Houghton as President and Chief Executive Officer
7. Elsevier Appoints New President of Elsevier CPM Resource Center
8. GenWay Biotech Appoints New Vice President of Custom/OEM
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
11. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment ... in 2021, according to Medical Equipment & ... by Freedonia Focus Reports. Continued increases in demand for ... aging of the population and supported by gains in ... equipment and supplies. New product introductions will also drive ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... 24, 2017 , ... Every year, thousands of dedicated Higher Education and K12 ... event is coupled with a dynamic theme like Camp Canvas; this year, they’ve managed ... 0017. , To extend their partnership with Canvas beyond the LMS integration, Modo ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... media initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care ... one of the leading causes of long term skin conditions, including cancer. ...
(Date:7/24/2017)... ... ... although people are taking more steps to protect themselves from sunburn, half of all adults ... within the past year. It’s common and people have been dealing with them since the ... become conscientious of the risks that accompany sunburns. , The team at AloeVera.com , ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of the nationally ... on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air about an ... China. , The article by Zidor Aldama described the situation in which Chinese children ...
Breaking Medicine News(10 mins):